Putting microRNAs on the stem cell map

August 7, 2008

Embryonic stem cells are always facing a choice—either to self-renew or begin morphing into another type of cell altogether. It's a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key regulators known as "master transcription factors," proteins that switch gene expression on or off.

In the past few years, scientists in the lab of Whitehead Member Richard Young and their colleagues have mapped out key parts of this regulatory circuitry, but the genes that produce the tiny snippets of RNA known as microRNAs have until now been a missing piece of the map. Since microRNAs are a second set of regulators that help to instruct stem cells whether to stay in that state, they play key roles in development.

Young and colleagues have now discovered how microRNAs fit into the map of embryonic stem cell circuitry. With this map, the scientists have moved one step closer to understanding how adult cells can be reprogrammed to an embryonic state and then to other types of cells, and to understanding the role of microRNAs in cancer and other diseases.

"By understanding how master transcription factors turn microRNAs on and off, we now see how these two groups of gene regulators work together to control the state of the cell," says Young, senior author on the study reported in the August 8 issue of Cell. "MicroRNAs are a special class of molecules because they not only contribute to cellular control but they play important roles in disease states such as cancer."

Previous studies had shown that the microRNA machinery is important in maintaining embryonic stem cells in their embryonic state, but offered only partial views of how microRNA genes fit in with the overall gene regulation circuitry. To do so required mapping the sites in the genome from which microRNA genes start, explains Stuart Levine, co-lead author on the paper and postdoctoral scientist in Young's lab.

"Knowing where genes start is essential to understanding their control," says Levine. "Based on our knowledge of microRNA gene start sites we were able to discover how these genes are controlled by the master transcription factors."

The researchers first created genome-wide maps of human and mouse embryonic stem cells that pinpoint where transcription factors bind to DNA and launch gene expression. This pinpointed where four master transcription factors (known as Oct4, Sox2, Nanog and Tcf3) were occupying sites where microRNA genes start to be transcribed. They found that the four core transcription factors are interacting with two key sets of microRNA genes. One set of microRNA genes is actively expressed in embryonic stem cells. The other set is silenced in those cells by other gene regulatory proteins known as Polycomb proteins. These proteins repress genes that are key for later development, a role previously described by Young lab researchers and their colleagues.

"We now have a list of what microRNAs are important in embryonic stem cells," says Alex Marson, co-lead author on the paper and an MD/PhD student in the Young lab. "This gives us clues of which microRNAs you might want to target to direct an embryonic stem cell into another type of cell. For example, you might be able to harness a microRNA to help drive an embryonic stem cell to become a neuron, aiding with neurodegenerative disease or spinal cord injury."

Moreover, the results give scientists a better platform for analyzing microRNA gene expression in cancer and other diseases. "We and others are finding that the overall gene circuitry for embryonic stem cells and cancer cells is very similar," notes Marson. "Now that we have connected the circuitry to microRNAs, we can begin to compare microRNAs that are regulated in embryonic stem cells to those in cancer cells."

Source: Whitehead Institute for Biomedical Research

Explore further: Finding a key to unlock blocked differentiation in microRNA-deficient embryonic stem cells

Related Stories

Study finds how to increase the survival time of stem cells

November 9, 2017

A team of researchers from the Faculty of Medicine at the University of Coimbra, led by Dr. Lino Ferreira, MIT Portugal Program Faculty and researcher at the Center for Neuroscience and Cell Biology (CNC) in collaboration ...

Newly discovered microRNA regulates mobility of tumor cells

October 27, 2017

Cancer cells can reactivate a cellular process that is an essential part of embryonic development. This allows them to leave the primary tumor, penetrate the surrounding tissue and form metastases in peripheral organs. In ...

Human skin cells transformed directly into motor neurons

September 7, 2017

Scientists working to develop new treatments for neurodegenerative diseases have been stymied by the inability to grow human motor neurons in the lab. Motor neurons drive muscle contractions, and their damage underlies devastating ...

Recommended for you

Energy-saving LEDs boost light pollution worldwide

November 22, 2017

They were supposed to bring about an energy revolution—but the popularity of LED lights is driving an increase in light pollution worldwide, with dire consequences for human and animal health, researchers said Wednesday.

Re-cloning of first cloned dog deemed successful thus far

November 22, 2017

(Phys.org)—A team of researchers with Seoul National University, Michigan State University and the University of Illinois at Urbana-Champaign has re-cloned the first dog to be cloned. In their paper published in the journal ...

Testing the advantage of being left-handed in sports

November 22, 2017

(Phys.org)—Sports scientist Florian Loffing with the Institute of Sport Science, University of Oldenburg in Germany has conducted a study regarding the possibility of left-handed athletes having an advantage over their ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.